Schweizer Monatsschrift für Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia / SSO
-
Schweiz Monatsschr Zahnmed · Jan 2007
[The Interdiscipilinary Orofacial Pain Consulting Service at the Center for Dental and Oral Medicine and Cranio-Maxillofacial Surgery, University of Zurich, Switzerland].
At the Center for Dental and Oral Medicine and Cranio-Maxillofacial Surgery of the University of Zurich, a new interdisciplinary pain consulting service was established in early 2005 due to the increasing number of referrals of orofacial pain patients to the center. This unit comprises specialists of various dental and medical disciplines as well as psychologists and physical therapists. This article highlights the most common clinical pictures of chronic orofacial pain patients and describes the organizational mechanisms associated with referrals to our interdisciplinary pain service.
-
Schweiz Monatsschr Zahnmed · Jan 2005
Review[Clonidine in oral medicine. Literature review and our experience].
There is a large experience in premedication with clonidine (Catapresan) for general anaesthesia. Clonidine is an alpha2-adrenoceptor agonist exerting central sympatholytic effects. Premedication with clonidine blunts the stress response to surgical stimuli and the narcotic and anaesthetic dose can be reduced. ⋯ However, Clonidine 2 microg/kg BW should be an adequate oral premedication dose for young and healthy patients scheduled for dental and facial surgery procedures performed under local anaesthesia in the ambulatory setting. In elderly patients clonidine 2 microg/kg BW administered orally should not be exceeded to avoid excessive hypotension and sedation. Bradycardia is a contraindication for the use of clonidine.
-
Schweiz Monatsschr Zahnmed · Jan 2005
[Therapeutic local anesthesia for the management of atypical odontalgia. A clinical case series].
The management of patients diagnosed with atypical odontalgia (AO) is a challenging task. The aim of this longitudinal clinical case series was to document the effect of a 4% carticaine solution without epinephrine among ten patients with AO. Once or on two successive days, 1.7 ml of the local anesthetics was injected buccally in the area of the perceived pain. ⋯ Patient satisfaction was not significantly associated with the amount of pain reduction. Considering the limited treatment options and their side effects, injections with epinephrine-free carticaine seem to be a measure worth to be taken into consideration. Although results gained from uncontrolled case series have to be interpreted with caution, the findings of this observational study sound promising.
-
Schweiz Monatsschr Zahnmed · Jan 2004
[Quality of the bristle-end rounding in ten brands of children's toothbrushes].
Animal and clinical studies have shown that sharp, unpolished toothbrush bristles may injure gingival tissue, and their contribution to cervical abrasion is widely discussed. The aim of the present study was to compare the end-roundness and smoothness of the bristle tips of ten commercially available children's toothbrushes (Elmex Lernzahnbürste, Aronal Oko Dent Kinder, Signal Kids, Dr. Best Milchzahn, Dr. ⋯ For all the other brands more than 50% of the bristle surfaces were judged as being acceptable. Despite of being flattened during usage, rounded bristle tips with a smooth surface are desirable. A good quality of bristle tips could only be observed in half of the brands examined.
-
Schweiz Monatsschr Zahnmed · Jan 2003
Comparative Study Clinical Trial Controlled Clinical Trial[Pain management after third molar extraction. Observations of the use of mefenamic acid and rofecoxib in the treatment of postoperative pain in the dental office].
Pain monitoring is often inadequate in the ambulant field to assure therapy results. Today NSAID take the centre in acute pain and inflammation control in dental interventions. Compared to conventional non-selective NSAID modern selective Cyclooxygenase-2 inhibitors (COX-2) provide the potential for improved compatibility and simplified medication with heightened effectiveness in acute postoperative toothaches. ⋯ With rofecoxib a continuous pain decrease with the lowest stand 48 hours after intervention was registered. One week after extraction the patient's satisfaction was in favour of rofecoxib, which showed a clearly prolonged analgetic effect over 24 hours. Additionally rofecoxib as a COX-2 selective inhibitor doesn't bear the risk for severe non-anticipatable gastrointestinal side effects or prolonged bleeding after surgical intervention.